Janssen Pharmaceutica NV

Johnson & Johnson Works with U.S. PEPFAR Program to Expand Access for HIV Treatment-Experienced Children in the Developing World

Together We Intend to Overcome Barriers to Access Treatment and Secure Supply of Pediatric Antiretroviral Therapy Formulations
Press Release

Vatican City,  Johnson & Johnson announced that Janssen Pharmaceutica NV, part of its Janssen Pharmaceutical Companies, is working with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) with the intention of expanding access to lifesaving HIV antiretroviral therapy (ART) for children in the developing world. The initiative seeks to address the fact that only about half of children under age 15 in the developing world are benefiting from ART. This was announced at a conference on pediatric HIV care taking place today in the Vatican City.

Subscribe to Janssen Pharmaceutica NV